Pet Serine Protease from Enteroaggregative Escherichia Coli Stimulates the Inflammatory Response Activating Human Macrophages

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2016 Jul 22

PMID 27439312

Citations 9

Authors

L M Rocha-Ramirez

U Hernandez-Chinas

D Banos-Rojas

J Xicohtencatl-Cortes

M E Chavez-Berrocal

G Rico-Rosillo

R Kretschmer

C A Eslava

Affiliations

Soon will be listed here.

Abstract

Background: Pet is a toxin from the family of Serine Protease Autotransporters of Enterobacteriaceae which was initially identified in Enteroaggregative Escherichia coli strains. This protease exhibits enterotoxin properties, damages the cell cytoskeleton and induces intestinal epithelium alterations, which are associated with a severe inflammatory process. An in-vitro study was conducted to evaluate the effect of Pet on the migration of human peripheral blood monocytes-derived macrophages and its participation in the activation of the early inflammatory response and cytokine expression.

Results: In the macrophage migration activation assay, Pet produced a similar effect to that induced by opsonized zymosan (ZAS). Regarding the cytokine expression, an increase of IL-8, TNF-α (pro-inflammatory) and IL-10 (anti-inflammatory) was identified. In addition to the above results, the nuclear translocation of NF-kB pp65 was also identified. These events are probably related to the inflammatory response identified in the histological examination of intestine rat samples inoculated with Pet during a ligated loop assay.

Conclusion: The results showed that Pet participates as an immunostimulant molecule for macrophages, which activates both their mobility and cytokine expression. These observations suggest that the toxin participates in the inflammatory process that is observed during the host infection by EAEC Pet producing.

Citing Articles

Polyvalent Bacterial Lysate with Potential Use to Treatment and Control of Recurrent Urinary Tract Infections.

Acevedo-Monroy S, Rocha-Ramirez L, Martinez Gomez D, Basurto-Alcantara F, Medina-Contreras O, Hernandez-Chinas U Int J Mol Sci. 2024; 25(11).

PMID: 38892345 PMC: 11173243. DOI: 10.3390/ijms25116157.

Plasmid-encoded toxin of cleaves complement system proteins and inhibits complement-mediated lysis .

Correa G, Freire C, Dibo M, Huerta-Cantillo J, Navarro-Garcia F, Barbosa A Front Cell Infect Microbiol. 2024; 14:1327241.

PMID: 38371299 PMC: 10869522. DOI: 10.3389/fcimb.2024.1327241.

The efficacy of anti-proteolytic peptide R7I in intestinal inflammation, function, microbiota, and metabolites by multi-omics analysis in murine bacterial enteritis.

Sun T, Liu X, Su Y, Wang Z, Cheng B, Dong N Bioeng Transl Med. 2023; 8(2):e10446.

PMID: 36925697 PMC: 10013768. DOI: 10.1002/btm2.10446.

Moringa isothiocyanate-1 inhibits LPS-induced inflammation in mouse myoblasts and skeletal muscle.

Sailaja B, Hassan S, Cohen E, Tmenova I, Farias-Pereira R, Verzi M PLoS One. 2022; 17(12):e0279370.

PMID: 36525453 PMC: 9757596. DOI: 10.1371/journal.pone.0279370.

Bacteria from gut microbiota associated with diarrheal infections in children promote virulence of Shiga toxin-producing and enteroaggregative pathotypes.

Izquierdo M, Lopez J, Gallardo P, Vidal R, Ossa J, Farfan M Front Cell Infect Microbiol. 2022; 12:867205.

PMID: 36017363 PMC: 9396624. DOI: 10.3389/fcimb.2022.867205.

References

Porter S, Wadhams G, Armitage J . Signal processing in complex chemotaxis pathways. Nat Rev Microbiol. 2011; 9(3):153-65. DOI: 10.1038/nrmicro2505. View

Strauman M, Harper J, Harrington S, Boll E, Nataro J . Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions. Infect Immun. 2010; 78(11):4958-64. PMC: 2976312. DOI: 10.1128/IAI.00580-10. View

Eslava C, Navarro-Garcia F, Czeczulin J, Henderson I, Cravioto A, Nataro J . Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli. Infect Immun. 1998; 66(7):3155-63. PMC: 108327. DOI: 10.1128/IAI.66.7.3155-3163.1998. View

Navarro-Garcia F, Sears C, Eslava C, Cravioto A, Nataro J . Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli. Infect Immun. 1999; 67(5):2184-92. PMC: 115956. DOI: 10.1128/IAI.67.5.2184-2192.1999. View

Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R . How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res. 2015; 2015:489821. PMC: 4452102. DOI: 10.1155/2015/489821. View

Strober W, Fuss I . Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011; 140(6):1756-1767. PMC: 3773507. DOI: 10.1053/j.gastro.2011.02.016. View

Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K . Biology of interleukin-10. Cytokine Growth Factor Rev. 2010; 21(5):331-44. DOI: 10.1016/j.cytogfr.2010.09.002. View

Oda T, Kojima Y, Akaike T, Ijiri S, Molla A, Maeda H . Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease. Infect Immun. 1990; 58(5):1269-72. PMC: 258619. DOI: 10.1128/iai.58.5.1269-1272.1990. View

Hebbelstrup Jensen B, Olsen K, Struve C, Krogfelt K, Petersen A . Epidemiology and clinical manifestations of enteroaggregative Escherichia coli. Clin Microbiol Rev. 2014; 27(3):614-30. PMC: 4135892. DOI: 10.1128/CMR.00112-13. View

10.

Medeiros P, Bolick D, Roche J, Noronha F, Pinheiro C, Kolling G . The micronutrient zinc inhibits EAEC strain 042 adherence, biofilm formation, virulence gene expression, and epithelial cytokine responses benefiting the infected host. Virulence. 2013; 4(7):624-33. PMC: 3906296. DOI: 10.4161/viru.26120. View

11.

Sepehri S, Khafipour E, Bernstein C, Coombes B, Pilar A, Karmali M . Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011; 17(7):1451-63. DOI: 10.1002/ibd.21509. View

12.

Henderson I, Czeczulin J, Eslava C, Noriega F, Nataro J . Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect Immun. 1999; 67(11):5587-96. PMC: 96930. DOI: 10.1128/IAI.67.11.5587-5596.1999. View

13.

Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning C . Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med. 2002; 196(8):1017-24. PMC: 2194041. DOI: 10.1084/jem.20020908. View

14.

Stecher B, Robbiani R, Walker A, Westendorf A, Barthel M, Kremer M . Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007; 5(10):2177-89. PMC: 1951780. DOI: 10.1371/journal.pbio.0050244. View

15.

Wang J, Lin H, Cheng M, Wong M . Chronic intermittent hypoxia modulates eosinophil- and neutrophil-platelet aggregation and inflammatory cytokine secretion caused by strenuous exercise in men. J Appl Physiol (1985). 2007; 103(1):305-14. DOI: 10.1152/japplphysiol.00226.2007. View

16.

Edwards L, Bajaj-Elliott M, Klein N, Murch S, Phillips A . Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS One. 2011; 6(10):e27030. PMC: 3203933. DOI: 10.1371/journal.pone.0027030. View

17.

Villaseca J, Navarro-Garcia F, Mendoza-Hernandez G, Nataro J, Cravioto A, Eslava C . Pet toxin from enteroaggregative Escherichia coli produces cellular damage associated with fodrin disruption. Infect Immun. 2000; 68(10):5920-7. PMC: 101555. DOI: 10.1128/IAI.68.10.5920-5927.2000. View

18.

Vial P, Robins-Browne R, Lior H, Prado V, Kaper J, Nataro J . Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis. 1988; 158(1):70-9. DOI: 10.1093/infdis/158.1.70. View

19.

Kumar H, Kawai T, Akira S . Pathogen recognition by the innate immune system. Int Rev Immunol. 2011; 30(1):16-34. DOI: 10.3109/08830185.2010.529976. View

20.

Parameswaran N, Patial S . Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010; 20(2):87-103. PMC: 3066460. DOI: 10.1615/critreveukargeneexpr.v20.i2.10. View